Biologic Therapy in Lupus Nephritis

Publisher： Karger

E-ISSN： 1660-2110|128|3-4|255-260

ISSN： 1660-2110

Source： Nephron Clin Pract, Vol.128, Iss.3-4, 2015-0, pp. : 255-260

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lupus Nephritis: From Pathogenesis to Targets for Biologic Treatment

By  

Nephron Clin Pract, Vol. 128, Iss. 3-4, 2015-0 ,pp. : 224-231

Karger

Access to resources Recommend Favorite

Biomarkers in lupus nephritis

By  

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (ELECTRONIC), Vol. 18, Iss. 2, 2015-02 ,pp. : 219-232

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical Assessment of Tacrolimus Therapy in Lupus Nephritis: One-Year Follow-Up Study in a Single Center

By  

Nephron Clin Pract, Vol. 113, Iss. 4, 2009-09 ,pp. : c330-c336

Karger

Access to resources Recommend Favorite

Targeted IgA Fc receptor I (FcαRI) therapy in the early intervention and treatment of pristane‐induced lupus nephritis in mice

By  

CLINICAL & EXPERIMENTAL IMMUNOLOGY, Vol. 181, Iss. 3, 2015-09 ,pp. : 407-416

John Wiley & Sons Inc

Access to resources Recommend Favorite

Rituximab in Systemic Lupus Erythematosus and Lupus Nephritis

By  

Nephron Clin Pract, Vol. 128, Iss. 3-4, 2015-0 ,pp. : 250-254

Karger

Access to resources Recommend Favorite